Detail of the clinical trial

Title of the trial A Phase IIB, Randomized, Double-Blinded, Placebo-Controlled Study of Low Dose Cytarabine and Lintuzumab Compared to Low Dose Cytarabine and Placebo in Patients 60 Years of Age and Older with Previously Untreated AML.
EudraCT number 2007-004761-17
Protocol number SG033-0003
Sponsor Seattle Genetics, Inc., Bothell, USA
Indications Hemato-oncology
Diagnosis acute myeloid leukaemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2008
Date of approval by Institute (SÚKL) 31.12.2008
Date of approval by EC 15.11.2008
Date of initiation CT in ČR
Date of ending CT in ČR 13.2.2009
Notice The study has not been started from administrative reasons.
Sites 2. Interní klinika, odd. klinické hematologie, FN Hradec Králové
Oddělení klinické hematologie, FNKV Praha 10
1. interní klinika, VFN Praha 2
Ústav hematologie a krevní transfuze, U Nemocnice 1, Praha 2
Interní hematolonkologická klinika, FN Brno

‹‹ Back to list